It may be a new year, but your generosity during last year’s Raising Hope at Work campaign continues to impact UF Health.
As a leading academic health center, UF Health views research as integral to our institution’s mission.
You and all Raising Hope at Work donors gave to areas that mean the most to you across patient care, research and education. Today, we want to share a few research fund highlights. Because of contributions to research-focused funds such as the 1923 Bladder Cancer Research Fund, the Alzheimer’s/Parkinson’s Disease Research Fund and the Women’s Cancer Research Fund, advances in translational science are becoming a reality.
Bladder cancer research is making new strides in improving care through clinical trials and discovering novel therapeutic targets. The U.S. Food and Drug Administration recently approved a new therapy for patients who participated in the trials. Women’s cancer research is a priority for the UF Health Cancer Center. There is an increased focus on screening and awareness for gynecologic cancers, including ovarian and cervical cancers. Several ongoing studies evaluate novel treatment approaches for ovarian cancer, which is often difficult to detect , and endometrial cancer.
At the Norman Fixel Institute for Neurological Diseases at UF Healthand Evelyn F. and William L. McKnight Brain Institute of the University of Florida, our teams have gained a wealth of knowledge about Alzheimer’s disease and Parkinson’s disease.
Our researchers are looking into the safety of deep brain stimulation in patients with mild Alzheimer’s disease. A recent focus has been on an imaging biomarker that shows promise in tracking Parkinson’s disease over time. The University of Florida also partners with the 1Florida Alzheimer’s Disease Research Center, which evaluates people who have memory disorders and other cognitive issues.
Your generosity makes these research advancements and much more, like the new Neuro-Imaging Suite at the Norman Fixel Institute, possible.